VPAResearch: Market Research Reports

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Cardiac Dysrhythmia pipeline product. ... provides key trends in Cardiac Dysrhythmia pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Cardiac Ischemia pipeline product. ... provides key trends in Cardiac Ischemia pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Cerebral Ischemia pipeline product. Mechanism of Action ...

... VPA Research has come up with a comprehensive report on Chronic Heart Failure pipeline. The report provides insights into different therapeutic candidates ... , recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Chronic Heart Failure pipeline product. Mechanism of ...

... in the US, Coronary artery diseases are among the most rapidly expanding disease in the US and world. Further, the US Coronary Heart disease market is sized ... recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Coronary Artery Disease pipeline product. Mechanism ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Coronary Restenosis pipeline product. ... provides key trends in Coronary Restenosis pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... (VTE) is classified further as deep vein thrombosis (DVT) and pulmonary embolism (PE). In DVT, the clot in veins lies deep inside muscled while in PE, the ... , recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Deep Vein Thrombosis pipeline product. Mechanism of ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Dilated Cardiomyopathy pipeline product. ... key trends in Dilated Cardiomyopathy pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

2018 Essential Hypertension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Essential Hypertension Market is a comprehensive report on Essential Hypertension market. To assist researchers, investors and business development managers, VPA Research ...

2018 Haemorrhagic Shock Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Haemorrhagic Shock Market is a comprehensive report on Haemorrhagic shock pipeline worldwide. To assist researchers, investors and business development managers, VPA ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Hemorrhagic Shock pipeline product. ... provides key trends in Hemorrhagic Shock pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Hypertrophic Cardiomyopathy pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Hypotension pipeline product. Mechanism of Action and ...

2018 Idiopathic Hypertension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Idiopathic Hypertension Market is a comprehensive report on idiopathic hypertension market. To assist researchers, investors and business development managers, VPA Research ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Intermittent Claudication pipeline product. ... key trends in Intermittent Claudication pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Irregular Heartbeat pipeline product. ... provides key trends in Irregular Heartbeat pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... Research has come up with a comprehensive report on Ischaemic Heart Disorders pipeline. The report provides insights into different therapeutic candidates ... recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Ischaemic Heart Disorders pipeline product. Mechanism of ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Ischemia-Reperfusion Injury pipeline product. Mechanism of Action ...

... Research has come up with a comprehensive report on Left Ventricular Dysfunction pipeline. The report provides insights into different therapeutic ... recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Left Ventricular Dysfunction pipeline product. Mechanism ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Myocardial Ischemia pipeline product. ... provides key trends in Myocardial Ischemia pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... estimated 0.2 billion population is affected worldwide and the market size of Peripheral Arterial Disease (PAD) is estimated to be around $4.5 billion. To assist researchers, ... has come up with a comprehensive report on Peripheral Arterial Disease (PAD) pipeline. The report provides insights into different ...

... estimated 0.2 billion population is affected worldwide and the market size of Peripheral Vascular Disease (PVD) is estimated to be around $4.5 billion. To assist researchers, ... has come up with a comprehensive report on Peripheral Vascular Disease (PVD) pipeline. The report provides insights into different ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Pulmonary Embolism pipeline product. ... provides key trends in Pulmonary Embolism pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynauds Disease pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynaud's Phenomenon pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynaud's Syndrome pipeline product. Mechanism of Action ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Reoxygenation Injury pipeline product. ... provides key trends in Reoxygenation Injury pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Restenosis pipeline product. Mechanism of Action and ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Septic Shock pipeline product. Mechanism ... provides key trends in Septic Shock pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... Research has come up with a comprehensive report on Sickle Cell Disease Or Sickle Cell Anemia pipeline. The report provides insights into different therapeutic ... each product, the report provides key trends in Sickle Cell Disease Or Sickle Cell Anemia pipeline studies. The products under development are ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Thromboembolism pipeline product. Mechanism of Action and ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Vaso-Occlusive Crisis pipeline product. ... key trends in Vaso-Occlusive Crisis pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Ventricular Tachycardia pipeline product. ... key trends in Ventricular Tachycardia pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Constipation pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Diabetic gastroparesis pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Diarrhea pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Dyspepsia pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Enterocolitis pipeline product. Mechanism of Action and ...

... 15 companies and universities are focusing on developing treatment options for Eosinophilic Esophagitis. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Eosinophilic Esophagitis pipeline product. ...

... universities are focusing on developing treatment options for Exocrine Pancreatic Insufficiency. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Exocrine Pancreatic Insufficiency pipeline product. ...

Gastritis is the inflammation of mucosa, lining of stomach, that can last for shorter periods or longer durations. Infection, alcohol and intake of NSAIDs lead to gastritis. ... /IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other ...

... Gastroesophageal Reflux Disease (GERD). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Gastroesophageal Reflux Disease (GERD ... the report provides key trends in Gastroesophageal Reflux Disease (GERD) pipeline studies. The products under ...

... billion market in the US alone, Hepatic Encephalopathy is a GI disorder affecting around 2 million people in the country. Hepatic Encephalopathy (HE) is a neuropsychiatric syndrome with ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatic Encephaopathy ...

... 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding and ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) pipeline product ...

... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Irritable Bowel Syndrome pipeline product. Mechanism of Action ...

... Over 20 companies and universities are focusing on developing treatment options for Liver Cirrhosis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Cirrhosis pipeline product. ...

... Over 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) ...

... Opioid Induced Constipation (OIC). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Opioid Induced Constipation (OIC ... , the report provides key trends in Opioid Induced Constipation (OIC) pipeline studies. The products under development ...

... Over 30 companies and universities are focusing on developing treatment options for Oral Mucositis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Oral Mucositis pipeline product. ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Pancreatitis pipeline product. Mechanism of Action and ...